In vitro susceptibility of Burkholderia cepacia to ceftazidime-avibactam: A systematic review

In vitro susceptibility of Burkholderia cepacia to ceftazidime-avibactam: A systematic review

Background: Burkholderia cepacia complex (BCC) is a group of multi-drug resistant (MDR) pathogens that are challenging to treat, especially in cystic fibrosis (CF) patients. Ceftazidime-avibactam is a promising antibiotic combination for treating BCC infections, but its efficacy requires further in...

Full description

Saved in:
Bibliographic Details
Main Authors: Abolfazl Rafati Zomorodi, Leila Ghanbari_Afra, Hossein Faridafshar, Seyed Nooreddin Faraji, Fatemeh Zarepour, Maryamosadat Mavaei, Mohammad Rahmanian
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:New Microbes and New Infections
Subjects:
Burkholderia cepacia
Ceftazidime/avibactam
Cystic fibrosis
Respiratory tract infections
Systematic review
Online Access:http://www.sciencedirect.com/science/article/pii/S205229752500040X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items